Affiliation:
1. Department of Human Health and Nutritional Sciences, University of Guelph, Guelph, ON N1G 2W1, Canada
2. Department of Health Sciences, Carleton University, Ottawa, ON K1S 5B6, Canada
Abstract
Altered intestinal health is also associated with the incidence and severity of many chronic inflammatory conditions, which could be attenuated via dietary n-3 PUFA interventions. However, little is known about the effect of lifelong exposure to n-3 PUFA from plant and marine sources (beginning in utero via the maternal diet) on early life biomarkers of intestinal health. Harems of C57Bl/6 mice were randomly assigned to one of three isocaloric AIN-93G modified diets differing in their fat sources consisting of the following: (i) 10% safflower oil (SO, enriched in n-6 PUFA), (ii) 3% flaxseed oil + 7% safflower oil (FX, plant-based n-3 PUFA-enriched diet), or (iii) 3% menhaden fish oil + 7% safflower oil (MO, marine-based n-3 PUFA-enriched diet). Mothers remained on these diets throughout pregnancy and offspring (n = 14/diet) continued on the same parental diet until termination at 3 weeks of age. In ileum, villi:crypt length ratios were increased in both the FX and MO dietary groups compared to SO (p < 0.05). Ileum mRNA expression of critical intestinal health biomarkers was increased by both n-3 PUFA-enriched diets including Relmβ and REG3γ compared to SO (p < 0.05), whereas only the FX diet increased mRNA expression of TFF3 and Muc2 (p < 0.05) and only the MO diet increased mRNA expression of ZO-1 (p < 0.05). In the proximal colon, both the FX and MO diets increased crypt lengths compared to SO (p < 0.05), whereas only the MO diet increased goblet cell numbers compared to SO (p < 0.05). Further, the MO diet increased proximal colon mRNA expression of Relmβ and REG3γ (p < 0.05) and both MO and FX increased mRNA expression of Muc2 compared to SO (p < 0.05). Collectively, these results demonstrate that lifelong exposure to dietary n-3 PUFA, beginning in utero, from both plant and marine sources, can support intestinal health development in early life. The differential effects between plant and marine sources warrants further investigation for optimizing health.
Funder
Natural Sciences and Engineering Research Council of Canada
Canadian Foundation for Innovation (CFI) John R. Evans Leaders Fund
Ontario Research Fund (ORF) Research Infrastructure (RI) Small Infrastructure Fund
Reference81 articles.
1. Human Intestinal Barrier Function in Health and Disease;Wells;Clin. Transl. Gastroenterol.,2016
2. Gut barrier disruption and chronic disease;Martel;Trends Endocrinol. Metab.,2022
3. Usuda, H., Okamoto, T., and Wada, K. (2021). Leaky Gut: Effect of Dietary Fiber and Fats on Microbiome and Intestinal Barrier. Int. J. Mol. Sci., 22.
4. Aleman, R.S., Moncada, M., and Aryana, K.J. (2023). Leaky Gut and the Ingredients That Help Treat It: A Review. Molecules, 28.
5. Leaky gut—Concept or clinical entity?;Quigley;Curr. Opin. Gastroenterol.,2016